Fort Point Capital Partners LLC Gilead Sciences, Inc. Transaction History
Fort Point Capital Partners LLC
- $803 Million
- Q3 2024
A detailed history of Fort Point Capital Partners LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fort Point Capital Partners LLC holds 5,333 shares of GILD stock, worth $496,342. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,333
Previous 5,187
2.81%
Holding current value
$496,342
Previous $355,000
25.92%
% of portfolio
0.06%
Previous 0.05%
Shares
19 transactions
Others Institutions Holding GILD
# of Institutions
1,942Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.7 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.12 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.75 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.6 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $117B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...